In a September 2025 judgment a US Appeals Court confidently proclaimed the matter as being a “straightforward contract interpretation case”. It is.
The insured claimed under a Marine Open Cargo Policy for damage to blood plasma that underwent a harmful temperature variation due to a delay in shipment. As a result of a “FDA hold”